RE: Piled into GCAT: low AISC, production up, royalty financing more than mcap + JV coming. Soon 2 producing projects. £100mil mcap target9 Aug 2023 13:14
I don't see the need for argument on here. I think the basic equation here is actually very simple. IF RM delivers on everything he is talking about delivering right now re Kili and TZ, then there will definitely be upside from here (and potentially lots of it) - let's call this Scenario A. The only question left under Scenario A would be about the "speed" of that upside. The answer to this will come from the Prospectus, which will give an idea of how much selling overhang GCAT has taken on to get to Scenario A. (To be fair, not all of the cheap shares will have gone to selling entities, there might be some who will want to hold/invest their shares for the long run.)
So each of just needs to decide how much belief we have that Scenario A is about to be delivered. Because we were in this situation last year, and RM did not deliver on what he was promising, I am NOT prepared to invest on the basis of belief once again. I don't have that trust and confidence to do so. It's not just about GCAT/RM, but as OCIM demonstrated, these financiers can walk away last minute. Therefore, I will now wait for RNS confirmation of the key issues (financing, JV and Prospectus).
I think this is the key decision that each of us need to make. Are we willing to invest on belief, trust and conviction that Scenario A is about to be delivered will be delivered? Or would be rather wait for RNS confirmation and take out the high risk element. Sometimes in deciding this you might look at the share price, but with the amount of dilution already taken on, and current share price performance, I don't see much probability of the share price taking off here before RNS confirmation. In fact, looks like the share price will wait for RNS confirmation as well. All imo and dyor